International Journal of Nephrology / 2017 / Article / Tab 6

Clinical Study

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 6

BMD at the distal third of radius.

Baseline (% of YAM)1 year (% of YAM)% change

Denosumab56.7 ± 7.258 ± 7.92.6 ± 4.4%
Control54.7 ± 1152.3 ± 10.1−4.5 ± 7.7%

BMD: bone mineral density; YAM: young adult mean.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.